Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,304 | 63,212 | 69,142 | 31,185 | 34,303 |
| Receivables | 97 | 148 | 124 | 606 | 112 |
| TOTAL | $59,268 | $63,823 | $69,421 | $31,947 | $34,621 |
| Non-Current Assets | |||||
| PPE Net | 709 | 748 | 721 | 748 | 639 |
| Intangibles | 36,616 | 40,647 | 40,850 | 41,053 | 38,784 |
| Other Non-Current Assets | 66 | 66 | 66 | 66 | 108 |
| TOTAL | $37,391 | $41,461 | $41,637 | $41,867 | $39,531 |
| Total Assets | $96,659 | $105,284 | $111,058 | $73,814 | $74,152 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,617 | 5,463 | 7,694 | 5,913 | 6,105 |
| TOTAL | $4,219 | $6,065 | $8,296 | $6,515 | $8,707 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 602 | N/A | 602 | 602 | 602 |
| TOTAL | $3,362 | $3,513 | $3,664 | $3,814 | $3,965 |
| Total Liabilities | $7,581 | $9,578 | $11,960 | $10,329 | $12,672 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,611 | 1,610 | 1,610 | 1,598 | 1,342 |
| Common Shares | 403 | 403 | 403 | 338 | 328 |
| Retained earnings | -345,999 | -337,720 | -332,473 | -325,471 | -322,847 |
| TOTAL | $89,078 | $95,706 | $99,098 | $63,485 | $61,480 |
| Total Liabilities And Equity | $96,659 | $105,284 | $111,058 | $73,814 | $74,152 |